TORONTO, June 5, 2024 /CNW/ -- Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to design and construct a ...

The acquisition of 3P innovation's RFF Cell enables Dalton to address larger segments of the pharmaceutical market and serve customers with greater global patient populations. TORONTO — Pharmaceutical ...

Dalton Pharma Services has announced expanded cGMP sterile powder filling capabilities as part of its ongoing focus on sterile processing and manufacturing. The expansion includes the addition of a ...

In line with Dalton's ongoing mission to adopt cutting-edge technology, this strategic investment not only expands the collaboration between the two organisations, but it also enables Toronto-based ...